UBS raises Partners Group stock price target to CHF1,271 on deal activity

UBS raised its price target for Partners Group Holding AG (PGHN) to CHF1,271.00 from CHF1,266.00, maintaining a Buy rating, despite the Swiss private equity firm facing recent valuation pressure from volatile markets, muted transaction activity, and a weakening USD against the CHF. The investment bank anticipates a sharp pickup in sector deal activity, leading to materializing exits and a return to average performance fees, suggesting current valuations, which imply a 15% discount to the 10-year average P/E, do not reflect this improved outlook.

Analysis

UBS has reiterated its 'Buy' rating on Partners Group Holding AG (PGHN) while marginally increasing its price target to CHF 1,271.00 from CHF 1,266.00. This bullish stance persists despite recent headwinds that have pressured the Swiss private equity firm's valuation, including muted transaction activity and significant financial drag from the U.S. dollar's double-digit weakening against the Swiss franc. The core of the investment bank's thesis is a forward-looking expectation of a sharp recovery in sector deal activity, which is anticipated to facilitate asset exits for Partners Group and drive performance fee contributions back toward through-the-cycle averages. Crucially, UBS argues this improved outlook is not reflected in the current stock price, highlighting that the 12-month forward price-to-earnings ratio trades at a 15% discount to its 10-year historical average. This valuation gap exists even while acknowledging persistent challenges related to U.S. evergreen fund flows.

Key Decisions for Investors

• Investors could view the current 15% valuation discount to the 10-year average P/E as a potentially attractive entry point, aligning with the analyst's thesis that an expected recovery in deal activity is not yet priced in.
• It is critical to monitor the pace of private market M&A and portfolio exits, as the materialization of these events is the primary catalyst for the anticipated normalization of performance fees.
• Continue to assess currency risk, specifically the USD/CHF exchange rate, and reports on U.S. evergreen fund flows, as these remain the key headwinds that could dampen earnings and asset growth.